Literature DB >> 19177904

Characterization of multidrug resistance-associated protein mRNAs expression profiles in Caco-2 and HT-1080 cell lines induced by methotrexate.

K Ikeda1, M Myotoku, Y Hirotani.   

Abstract

An efflux function induced by multidrug resistance-associated proteins (MRPs) contributes to the mechanisms of resistance to methotrexate (MTX). Since it has been reported that the human Caucasian colon adenocarcinoma cell line (Caco-2) shows high MRPs expression, it is assumed that Caco-2 cells are resistant to MTX. Alternatively, the human fibrosarcoma cell line (HT-1080) has been reported to be highly sensitive to MTX. In this study, the difference in the growth-inhibitory activity of MTX in these cell lines was compared as a characteristic of sensitivity. Subsequently, the characterization of MRP (1-8) mRNAs expression profiles before and after MTX exposure in these cell types was examined with the multiplex reverse-transcription-polymerase chain reaction (RT-PCR) method. It was demonstrated that the expressions of MRP2, MRP3, MRP6, and MRP8 mRNAs in the HT-1080 cells were lower than those in the Caco-2 cells and that only MRP5 mRNA expression was induced in the Caco-2 cells after MTX treatment. The MRP mRNAs expression profiles between these two cell lines could be differentiated widely. The characterization of MRPs profiles might be associated with resistance to MTX in cells. Additionally, this multiplex RT-PCR method would be beneficial for further time-dependence investigations of the MRP mRNAs expression profiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19177904

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Absorption and metabolism characteristics of rutin in Caco-2 cells.

Authors:  Xiaofang Zhang; Jinhui Song; Xiaopeng Shi; Shan Miao; Yan Li; Aidong Wen
Journal:  ScientificWorldJournal       Date:  2013-10-02

2.  Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells.

Authors:  Abilasha Gayani Jayathilake; Paul Vincent Senior; Xiao Qun Su
Journal:  BMC Complement Altern Med       Date:  2016-08-30       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.